Experimental leukemia combination proves toxic for older, frail patients

(SWOG) About 32% of older, sicker patients enrolled on a leukemia clinical trial experienced serious side effects from a treatment that combined a chemotherapy and an immunotherapy drug, leading investigators to pause the trial and the US Food and Drug Administration to eventually pull the combination from the current study.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news